Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision

首页> 外文期刊>Diseases of the Colon and Rectum >Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision

【24h】

Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision

机译：佐剂化疗不会改善Neoadjuvant ChemorAdiotapy和总培养的切除术后2阶段或第3阶段直肠癌患者的复发存活

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND:

机译：背景：

著录项

来源
《Diseases of the Colon and Rectum》 |2020年第4期|共14页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
Adjuvant chemotherapy; Locally advanced rectal cancer; Neoadjuvant chemoradiotherapy; Rectal cancer; Total mesorectal excision; Total neoadjuvant therapy;

机译：佐剂化疗;局部晚期直肠癌;Neoadjuvant ChemorAdiotapy;直肠癌;总部分切除术;全新辅助疗法;

相似文献

外文文献
中文文献
专利

1. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision [J] . Diseases of the Colon and Rectum . 2020,第4期

机译：佐剂化疗不会改善Neoadjuvant ChemorAdiotapy和总培养的切除术后2阶段或第3阶段直肠癌患者的复发存活
2. Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy [J] . Hongzhi Li, Honggang Wang, Shanshan Shao, OncoTargets and therapy . 2020,第2期

机译：预处理白蛋白与纤维蛋白原比例独立地预测了在Neoadjuvant ChemoRadioCherapy疗法中患有局部晚期直肠癌患者患者的化疗反应和预后
3. Omitting adjuvant chemotherapy in patients with rectal cancer who received neoadjuvant chemoradiation followed by total mesorectal excision and achieved a pathological complete response [J] . Polanco Patricio, Huerta Sergio The American Journal of Surgery . 2018,第2期

机译：省略辅助化疗，接受Neoadjuvant Chemoradiation的直肠癌患者，然后进行了培养基切除总体切除并实现了病理完全反应
4. Radiomics analysis of DWI data to identify the rectal cancer patients qualified for local excision after neoadjuvant chemoradiotherapy [C] . Zhenchao Tang, Zhenyu Liu, Xiaoyan Zhang, SPIE Medical Imaging Conference . 2018

机译：DWI数据的放射线学分析，以鉴定新辅助放化疗后符合局部切除资格的直肠癌患者
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision and Postoperative Adjuvant Chemotherapy [O] . Taeryool Koo, Changhoon Song, Jae-Sung Kim, -1

机译：淋巴结比率对ypStage III直肠癌患者的新辅助放化疗全直肠系膜切除术和术后辅助化疗后的肿瘤结局的影响
7. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy. [O] . Taeryool Koo, Changhoon Song, Jae-Sung Kim, 2015

机译：淋巴结转移率对ypstage III直肠癌患者肿瘤学结局的影响，新辅助放化疗，全直肠系膜切除术和术后辅助化疗。

Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision

摘要

著录项

相似文献

相关主题

期刊订阅